Beauty Health (NASDAQ:SKIN) Trading Down 1.5% – Should You Sell?

Shares of The Beauty Health Company (NASDAQ:SKIN) fell 1.5% during mid-day trading on Friday . The stock traded as low as $0.7446 and last traded at $0.7738. 1,870,061 shares were traded during trading, an increase of 21% from the average session volume of 1,546,612 shares. The stock had previously closed at $0.7856.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on SKIN. Roth Mkm restated a “buy” rating and set a $2.00 price target (down from $2.50) on shares of Beauty Health in a research note on Wednesday, May 20th. Zacks Research upgraded shares of Beauty Health from a “strong sell” rating to a “hold” rating in a research note on Monday, March 16th. TD Cowen cut their price objective on shares of Beauty Health from $1.65 to $1.50 and set a “hold” rating for the company in a report on Monday, March 16th. Canaccord Genuity Group cut their price objective on shares of Beauty Health from $1.50 to $1.00 and set a “hold” rating for the company in a report on Friday, May 1st. Finally, Benchmark reaffirmed a “hold” rating on shares of Beauty Health in a report on Friday, March 13th. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $2.02.

Beauty Health Stock Performance

The company’s fifty day simple moving average is $0.85 and its 200 day simple moving average is $1.16. The company has a current ratio of 1.79, a quick ratio of 1.48 and a debt-to-equity ratio of 4.37. The stock has a market capitalization of $100.28 million, a P/E ratio of -4.55 and a beta of 1.12.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.04. Beauty Health had a negative net margin of 2.03% and a negative return on equity of 9.38%. The firm had revenue of $64.91 million during the quarter, compared to the consensus estimate of $66.28 million. As a group, sell-side analysts forecast that The Beauty Health Company will post -0.14 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Mirabella Financial Services LLP raised its position in Beauty Health by 21.3% in the 3rd quarter. Mirabella Financial Services LLP now owns 15,596,277 shares of the company’s stock worth $31,037,000 after purchasing an additional 2,734,728 shares during the period. Hillsdale Investment Management Inc. purchased a new position in shares of Beauty Health in the third quarter valued at about $293,000. Caprock Group LLC purchased a new position in shares of Beauty Health in the third quarter valued at about $62,000. Kapitalo Investimentos Ltda increased its position in shares of Beauty Health by 45.1% in the third quarter. Kapitalo Investimentos Ltda now owns 45,787 shares of the company’s stock valued at $91,000 after acquiring an additional 14,240 shares during the period. Finally, Renaissance Technologies LLC increased its position in shares of Beauty Health by 29.6% in the first quarter. Renaissance Technologies LLC now owns 283,791 shares of the company’s stock valued at $253,000 after acquiring an additional 64,900 shares during the period. 93.26% of the stock is owned by institutional investors.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.